WHO and FIGO Endorse Non-Pneumatic Anti-Shock Garment to Address Postpartum Hemorrhage
At the recent International Federation of Gynecology and Obstetrics’ (FIGO) World Congress held in Rome, Dr. Suellen Miller of the UCSF Safe Motherhood Program, lead researcher on the non-pneumatic anti-shock garment (NASG), held a series of scientific presentations on the impact of the NASG on women suffering from postpartum hemorrhage. Interventions using the garment, led by Dr. Miller and partners including Pathfinder International, clearly demonstrated that the non-pneumatic anti-shock garment, when combined with standard care, contributes to a reduction of mortality from postpartum hemorrhage, especially for women in severe shock.
Endorsement of the Non-Pneumatic Anti-Shock Garment
Both the World Health Organization and FIGO have given early endorsement to the NASG before trials are complete, including it in their 2012 guidelines to address prevention and treatment of postpartum hemorrhage.
“The NASG is a true life-saving device for women in shock and close to death due to postpartum hemorrhage. This is a major life-saving support device, easy to administer by any health personnel and needs to be available for pregnant women everywhere and particularly in low resource countries.” (FIGO endorsement)
Pathfinder has implemented our clinical and community action to address maternal and newborn health in 6 countries over the past 5 years in Africa, Asia and Latin America. This is a holistic approach that addresses emergency obstetric care through advocacy, facility, and community interventions for preventing and treating major killers of women. The non-pneumatic anti-shock garment plays a critical role for women experiencing postpartum hemorrhage for whom prevention and early treatment do not work. The garment stabilizes them for transport and helps stop the bleeding until they can reach the facility services they need. Pathfinder’s programs have shown how to introduce and scale-up the NASG effectively within a continuum of care to address maternal mortality and help reach MDG5 by 2015.
Read Pathfinder’s full technical memo on the recent endorsement.
For more information, please contact email@example.com or call 617.972.1291.
Call for Expression of Interest in Reproductive, Maternal, and Neonatal Health Innovation Fund Grants
Ethiopia's Federal Ministry of Health has initiated the Reproductive, Maternal, and Neonatal Health Innovation Fund (RIF). The Fund will finance innovative projects that address demand-side barriers in reproductive, maternal, and neonatal health. Deadline for submission of Expression of Interest to the Federal Ministry of Healthwill be September 15, 2014.
Pathfinder's Surjer Hashi Clinic (Smiling Sun) has unified Bangladesh's Teknaf community towards one goal: save pregnant mother. Among the many innovations introduced by clinic, one has been the demarcation of houses occupied by pregnant mothers with red flags - enabling neighbors to come together and help that particular family when required.